Related Experiment Video
Updated: Mar 7, 2026

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts
Published on: October 9, 2016
Redirecting RNA splicing by SMAD3 turns TGF-β into a tumor promoter
Veenu Tripathi1, Ying E Zhang1
1Laboratory of Cellular and Molecular Biology, Center for Cancer Research, National Cancer Institute , Bethesda, MD, USA.
Abstract:
Transforming growth factor β (TGF-β) is a well-known growth inhibitor of normal epithelial cells, but it is also secreted by solid tumors to promote cancer progression. Our recent discovery of SMAD3-PCBP1 complex with direct RNA-binding properties has shed light on how this conversion is implemented by controlling pre-mRNA splicing patterns.
Insights
Transforming growth factor beta (TGF-β) normally inhibits cell growth but promotes cancer when secreted by tumors. A newly discovered SMAD3-PCBP1 complex controls this switch by altering pre-mRNA splicing.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Signaling
Background:
- Transforming growth factor beta (TGF-β) paradoxically inhibits normal epithelial cell growth while promoting solid tumor progression.
- The dual role of TGF-β in cancer remains incompletely understood at the molecular level.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying TGF-β's switch from a tumor suppressor to a tumor promoter.
- To investigate the role of protein complexes in regulating gene expression in cancer.
Main Methods:
- Investigated the interaction between SMAD3 and PCBP1.
- Characterized the RNA-binding properties of the SMAD3-PCBP1 complex.
- Analyzed the impact of this complex on pre-mRNA splicing patterns.
Main Results:
- Discovered a novel complex formed by SMAD3 and PCBP1 with direct RNA-binding capabilities.
- Demonstrated that the SMAD3-PCBP1 complex directly influences pre-mRNA splicing.
- Identified this complex as a key regulator in the context of TGF-β signaling in cancer.
Conclusions:
- The SMAD3-PCBP1 complex is a critical mediator of TGF-β's pro-tumorigenic effects.
- Regulation of pre-mRNA splicing by the SMAD3-PCBP1 complex is a key mechanism driving cancer progression.
- Targeting this complex may offer new therapeutic strategies for solid tumors.
More Related Videos
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
11:06Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System
Published on: July 30, 2018
Related Concept Videos
TGF - β Signaling Pathway
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Abnormal Proliferation
The Ras Gene
Ras is a...
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...